Adherium Ltd has released a press release.
Accel Non-Renounceable Entitlement Offer to raise up to $4m
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Adherium
- $900K Capital Raise to Accelerate Smart Inhaler in US
- Adherium Secures $2.6M to Advance Smart Inhaler in US
- Management Change
- AstraZeneca selected Adherium Smartinhaler for its study
- Non-Renounceable Rights Issue Offer Completes
Later from Adherium
- Prospectus
- Successful Completion of Institutional Component of ANREO
- Replacement Prospectus
- Successful Completion of Retail Component of ANREO
- Adherium Appoints Dawn Bitz as CEO
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium